Sovateltide |
IRL-1620; PMZ-1620; SPI-1620 |
Approved |
University Of Illinois At Chicago |
Tyvalzi |
India |
Stroke |
Pharmazz Inc |
2023-05-31 |
Brain Ischemia; Biliary Tract Neoplasms; Carcinoma; Spinal Cord Injuries; Asphyxia Neonatorum; Brain Diseases; Stroke; Hypoxia-Ischemia, Brain; Dementia; Alzheimer Disease; Cerebral Infarction; Carcinoma, Non-Small-Cell Lung |
Details
|
Macitentan/Tadalafil |
|
Approved |
Actelion Pharmaceuticals Ltd |
OPSYNVI |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2024-03-22 |
Pulmonary Arterial Hypertension |
Details
|
Bosentan Hydrate |
ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 |
Approved |
F. Hoffmann-La Roche Ltd |
Stayveer, 全可利, Tracleer |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Ltd |
2001-11-20 |
Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial |
Details
|
Macitentan |
ACT-064992; Actelion-1; JNJ-67896062 |
Approved |
Actelion Pharmaceuticals Ltd |
Zependo, Opsumit, 傲朴舒 |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2013-10-18 |
Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure; Idiopathic Pulmonary Fibrosis; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Glioblastoma; Lung Diseases, Interstitial; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Anemia, Sickle Cell; Chronic Disease; Heart Defects, Congenital |
Details
|
Aprocitentan |
ACT-132577; AC-080; JNJ-2820 |
Approved |
Idorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals Ltd |
TRYVIO |
United States |
Hypertension |
Idorsia Pharmaceuticals Ltd |
2024-03-19 |
Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic |
Details
|